Brief: Reneo Pharmaceuticals, Inc. Q2 EPS USD -0.65
10/08/2023 12:38
Aug 10 (Reuters) - Reneo Pharmaceuticals, Inc. Q2 net income USD -19.5 million. * Q2 EPS USD -0.65
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker